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Papain, a phytotherapeutic agent, has been used in the treatment of eschars and as a debriding chemical agent to remove damaged
or necrotic tissue of pressure ulcers and gangrene. Its beneﬁts in these treatments are deemed eﬀective, since more than 5000
patients, at the public university hospital at Rio de Janeiro, Brazil, have undergone papain treatment and presented satisfactory
results. Despite its extensive use, there is little information about toxic and mutagenic properties of papain. This work evaluated
the toxic and mutagenic potential of papain and its potential antioxidant activity against induced-H2O2 oxidative stress in
Escherichia coli strains. Cytotoxicity assay, Growth inhibition test, WP2-Mutoxitest and Plasmid-DNA treatment, and agarose gel
electrophoresis were used to investigate if papain would present any toxic or mutagenic potential as well as if papain would display
antioxidantproperties.Papainexhibitednegativeresultsforalltests.ThisagentpresentedanactivityprotectingcellsagainstH2O2-
induced mutagenesis.
1.Introduction
The belief that natural medicines are much safer than synt-
hetic drugs has caused exceptional growth in human expo-
sure to natural products, as plants, phytotherapeutic agents,
and phytopharmaceutical products. This fact has lead to a
resurgence of scientiﬁc interest in their biological eﬀects. In
most countries there is no universal regulatory system insu-
ring the safety and activity of natural products and they
had not been suﬃciently investigated analytically or toxi-
cologically [1].
Herbal medicines can be potentially toxic to human
health. In this way, scientiﬁc research has shown that many
plants used in traditional and folk medicine are potentially
toxic, mutagenic, and carcinogenic [1–9].
Carica papaya L. (C. papaya L.) is the most important
species within the Caricaceae genus, being widely cultivated
for consumption as a fresh fruit, as juices, and as dried
and crystallized fruit. Papaya also has several industrial uses
[10–12]. Biochemically, its leaves and fruits are complex,
representing sources of several proteins and alkaloids with
important pharmaceutical, medical, and industrial appli-
cations. The juice is used for curing warts, cancer, and
tumors. Leaves have been poultice into nervous pain. The
hypoglycemic eﬀecthasbeenreported.Itisusedtotreatment
of infected wounds, malignant tumors, and burns [10].
The juice of ripe papaya displayed in vivo and in vitro
activities against oxidative stress [13, 14]. It is an eﬃcient
scavenger of highly reactive hydroxyl radicals (OH
•)f o r m e d
during 60Co irradiation [13].2 Journal of Biomedicine and Biotechnology
The green (unripe) papaya, which is rich in papain,
is used for dressing of ulcers. This treatment is described
as eﬀective and it is recommended in preference to other
dressings for chronic skin ulcers. It has been used in many
countries such as England, Nigeria, Ghana, Gambia, India,
and Jamaica [15]. In spite of its extensive use, the following
disadvantages were described, as problems concerning the
availability of green papaya and diﬃculties in preparing and
storing papaya [15].
The demonstration of the phytotherapeutic potential
of a given species is a diﬃcult task, since plant extracts
consist of complex mixtures of major compounds, minor
concomitant agents, and ﬁbers, which can all be involved
in the observed eﬀects. Thus, given the diﬃculties in
determining the contribution of a speciﬁc substance in the
biological eﬀects exerted by whole extracts, the aim of this
work was the study of papain isolated from C. papaya,w h i c h
possesses vast application in medicine.
Papain, a puriﬁed protein extracted from the latex of
the unripe papaya, is widely used by Brazilian nurses in
traditional medicine. It can be an alternative to green papaya
and it can be used as phytotherapeutic agent in the treatment
of pressure ulcers, gangrene, eschars, and as a debriding
chemical agent to remove damaged or necrotic tissue [16].
Papain is sometimes used in association with hydrous
magnesium silicate (talc). Its beneﬁts in these treatments
are deemed eﬀective, since more than 5000 patients at the
Pedro Ernesto University Hospital, at Rio de Janeiro/Brazil,
have undergone papain treatment and presented satisfactory
results [16]. Despite its extensive use, there is little infor-
mation about toxic, mutagenic, and antioxidant properties
of papain itself or even unripe papaya, which contains high
concentration of papain [12].
Short-term tests have been used to check compounds for
their ability to induce lesions in DNA, which may lead to
genotoxicity, cytotoxicity, or mutagenicity. The experimental
techniques using microbial cells such as Escherichia coli (E.
coli)a n dSalmonella typhimurium (S. typhimurium), as well
as assays using DNA as the target molecule, allowed the
development of new tools to investigate toxic and mutagenic
potentials of many physical and chemical agents and their
correlation with the eﬀects in eukaryotic systems [1, 17–20].
Hydrogen peroxide (H2O2) is a normal cell metabolite
formed in several enzymatic and nonenzymatic reactions.
H2O2 leads to oxidative stress, mutagenicity, loss of cell
function,andultimatelyapoptosisornecrosis[18,21,22].In
E. coli, a major component of the H2O2 toxicity is attributed
to DNA damage mediated by the Fenton reaction, which
generates reactive oxygen species (ROSs), such as OH
• [21–
27]. E. coli possesses a number of antioxidant enzymes and
DNA repair activities encoded by several genes (xthA, mutY,
oxyR, among others) to counteract DNA damage caused by
oxidative stress. Mutant strains lacking one or more of those
genes are usually hypersensitive to H2O2 [18, 21, 22, 26].
So, Blanco and coworkers (1998) designed a series of E. coli
WP2 tester strains (IC203 up to IC207, used in this study),
which are useful for the screening of mutations resulting
from oxidative stress as well in studies on antioxidants
[18].
It is well documented that oxidative damage has been
implicated in various systemic chronic diseases such as can-
cer, Alzheimer’s disease, rheumatoid arthritis, cardiovascular
disease, cataracts, and other ageing processes. Reactive oxy-
gen species (ROSs) are essential intermediates in oxidative
metabolism. Nonetheless, when generated in excess, ROSs in
various active forms can damage tissues [28].
In recent years, there has been a considerable interest in
ﬁnding natural antioxidants from plant materials to replace
synthetic molecules. Data from both scientiﬁc reports and
laboratory studies show that plants contain a large variety
of substances that possess antioxidant activity. Phytochem-
icals with antioxidant eﬀects include some cinnamic acids,
coumarins, diterpenes, ﬂavonoids, lignans, monoterpenes,
phenylpropanoids, tannins, and triterpenes. Natural antiox-
idants occur in all higher plants and in all parts of the plant
(wood, bark, stems, pods, leaves, fruit, roots, ﬂowers, pollen,
and seeds) [29, 30].
The present work was carried out to evaluate the
potential cytotoxic and mutagenic eﬀects of papain using
E. coli strains and plasmid DNA. In addition, we have also
investigated papain antioxidant and antimutagenic activities
against oxidative stress induced by H2O2.
2.ExperimentalProcedures
2.1. Bacterial Strains and Plasmid. E. coli strains AB1157
(wild type); BH20 (fpg); PQ65 (rfa); BW9091 (xthA);
DH5αF’IQ (pUC 9.1), WP2 (wild type); IC203 (uvrA
oxyR pKM101), IC204 (uvrAd e l [ umuDC]), IC205 (uvrA
del[umuDC] mutM), IC206 (uvrAd e l [ umuDC] mutY), and
IC207(uvrAd e l [ umuDC] mutM oxyR) were used in this
work [18, 29–34].
In order to prepare cultures to evaluate cytotoxic,
antioxidant, mutagenic eﬀects of papain and to perform
reverse mutation test, the strains were grown according to
previously described methods [8, 18].
Samples (∼107 cells) of the E. coli strain stocks were
taken from frozen vials (50% v/v glycerol) and grown in
liquid (10mL) LB medium at 37◦C, overnight with shaking
(Reciprocal Water Bath Shaker, model R76, New Brunswick,
ScienceCo.Inc,N.J.EUA)uptothestationarygrowthphase.
From the overnight culture, a sample containing 100μLw a s
added to 10mL of fresh LB medium and incubated at 37◦C
for 2 h, with shaking, to reach exponential growth phase (1-2
× 108 cells/mL). Then, cells were collected by centrifugation
(7,200 ×g in Sorvall SS-34 Rotor), washed twice with 0.9%
NaCl sterile solution, and resuspended in the same solution
for each indicated treatment [8].
Plasmid pUC 9.1 has been prepared according to a
previously described alkaline method [35].
2.2. Reagents, Phytotherapeutic and Chemical Agents. Bacto
agar, bacto tryptone, and bacto yeast extract were purchased
from Difco Laboratories, Detroit, USA. Nutrient broth was
purchased from Oxoid do Brasil, Ltda (Brazil). Papain
powder(fromC.papayaL.,30,000USP-U/mgstabilizedwith
sodium disulﬁte), sodium chloride, perhidrol (30% H2O2),
glucose, and tryptophan (Trp) were from Merck (Brazil);Journal of Biomedicine and Biotechnology 3
streptomycin, chloramphenicol, and ampicillin were from
Sigma (St. Louis, USA). Ultra pure water was obtained from
a Milli-Q water system from Millipore Corp, Bedford, MA,
USA.
Papain powder, protected against ambient light, was
suspended in 0.9% NaCl sterile solution, vigorously shaken
for 2 minutes at room temperature and immediately ﬁltered
through a sterile 0.22μm Millipore cellulose acetate mem-
brane to eliminate microbial contaminants. This solution
was associated or not with sterile talc (obtained after
autoclavation, 121◦C, 30 minutes). This association (talc and
papain) was prepared before each experiment.
For the tests, the concentration of papain was calculated
based on the amount administered to the patients. The
highest concentration of papain (500μg/mL) to which the
bacterial cultures were exposed is much greater than that
used in the wounds of patients during treatment.
2.3. Culture Media, Solutions, and Cell Growth. The culture
media,solutions,andcellgrowthwerepreparedaspreviously
described [8, 17, 18, 35].
Dilutions of the chemical preparations and bacterial
cultures were carried out with 0.9% NaCl sterile solution,
dimethyl sulfoxide (DMSO), or ultra pure Milli-Q water
[8, 17, 18].
2.4. Cytotoxicity Assay. In order to evaluate the potential
cytotoxic eﬀect of papain, culture aliquots (1mL) of E.
coli AB1157, PQ65, BH20, and BW9091 strains, in the
exponential growth phase, were incubated under shaking for
60 minutes at 37◦Cw i t hd i ﬀerent papain concentrations (0,
50, 250, and 500μg/mL 0.9% NaCl sterile solution).
In order to evaluate the cytotoxic eﬀect of papain
associated with talc, aliquots (1mL) of E. coli AB1157 and
BW9091 strains in exponential growth phase were incubated
with papain in combination with talc (500μg/mL) or talc
alone (500μg/mL). A sample was incubated in 0.9% NaCl
sterile solution, under the same conditions, as a negative
control. After the treatments, aliquots (100μL) were taken,
diluted with 0.9% NaCl sterile solution, and spread, in
duplicates, on LB-plates, following incubation at 37◦Cf o r
24 hours. The colony-forming units were then scored and
surviving fractions (SF = N60/N0) were expressed as the
mean of three experiments [8].
2.5. Growth Inhibition Test. In the growth inhibition test,
100μL( ∼108 cells) of a fresh overnight E. coli culture (in
LB medium) were added to 3mL of molten top agar and
poured onto LB plates supplemented with chloramphenicol
(20μg/mL) or ampicillin (20μg/mL), according to the tester
strain. Paper discs (5 mm diameter) were impregnated with
10μL of 0.9% NaCl sterile solutions containing one of the
following amounts of papain (5; 12.5; 25; 50; 100; 125;
250 and 500μg/paper disc), papain (100 or 500μg/paper
disc) associated with H2O2 (300μg/paper disc) or only H2O2
(300μg/paper disc) as a positive control. The impregnated
paper discs were placed on the center of plates and all
plates were incubated overnight at 37◦C. Inhibition halos
were measured (in mm) and expressed after calculating the
diﬀerence between the inhibition zone diameter and the disc
diameter [36].
2.6. Reverse Mutation Test in E. coli Strains (Mutoxitest). The
assays were performed according to Blanco et al. (1988);
E. coli IC203 and IC204 strains (both Trp−)w e r eg r o w n
in nutrient broth liquid medium for ∼16 hours at 37◦C
in agitation. A suspension of the overnight-cultured strains
(100μL) was transferred to sterile screw-top tubes with
2.5mL of 0.6% soft-agar at 45◦C and various concentrations
of papain (0, 12.5, 25, 50, 125, 250, and 500μg/plate) dis-
solved in 0.9% NaCl sterile solution. The total tube content
was spread immediately onto plates containing minimal
ET4 agar supplemented with tryptophan (0.01mg/plate)
and incubated for 48 hours at 37◦C. The number of Trp+
revertant colonies was determined and the reversion rate was
compared to control (negative and positive) plates. In these
experiments, each sample was assayed using duplicate plates
and the data presented was the mean of three experiments.
Theresultswereexpressedasthemean ±standarddeviations
(SDs). A sample was considered mutagenic when number of
revertants were higher than 2 for at least one of the tested
concentrations [17].
2.7. Plasmid DNA Treatment and Agarose Gel Electrophoresis.
Agarose gel electrophoresis (0.8%) was performed in order
to separate diﬀerent structural conformations of pUC 9.1
plasmid DNA after papain treatment: form I supercoiled
(SC)nativeconformation,formIIopencircle(OC)resulting
from single strand breaks, and form III linear (L) resulting
from double strand breaks. Plasmid DNA aliquots (200ng)
were treated with increasing concentrations of papain for
40 minutes at 25◦C and negative control was performed
using ultra pure H2O (Milli-Q). After treatments, each
sample was mixed with loading buﬀer (0.25% xylene cyanol
FF; 0.25% bromofenol blue; 30% glycerol in water) and
submittedtoagarosegelelectrophoresisinTrisacetate-EDTA
buﬀer, pH 8.0 at 6V/cm. After electrophoresis, the gel was
stained with ethidium bromide (0.5μg/mL) and the DNA
bands were visualized by ﬂuorescence in an ultraviolet DNA
transiluminator system [6, 35]. The assay was repeated, at
least three times, and the bands quantiﬁed with the Gel Pro
Analyzer3.0software(MediaCybernetics,SilverSpring,MD,
USA).
2.8. Statistical Analysis of Results. The results were analyzed
by ANOVA since (i) the data were normally distributed as
veriﬁed by the method Kolmogorov and Smirnov and (ii)
samples from populations had identical standard deviations
(SDs), as veriﬁed by the Bartlett method. ANOVA was
followed by the Student Newman Keuls multiple compar-
ison test using the statistical program InStat version 3.01
(GraphPad Software, San Diego, CA, USA). These analyses
compared the results obtained by the several treatments, at
diﬀerent papain concentrations, including the controls. A
signiﬁcance level of 5% was adopted to evaluate the data.4 Journal of Biomedicine and Biotechnology
Table 1
(a) Eﬀect of diﬀerent papain concentrations on the survival of E. coli strains. Exponentially growing cultures were centrifuged, washed with 0.9% NaCl
sterile solution, and suspended in the same solution. Aliquots (1mL) of these suspensions were incubated with diﬀerent papain concentrations or 0.9% NaCl
for 60 minutes, at 37◦C, with shaking. Afterwards, aliquots (100μL) were taken, diluted and plated onto LB medium for determining surviving fractions
(SF = N60/N0) for each strain at diﬀerent papain concentrations. Values are the mean of 3 independent experiments (6 determinations) with standard
deviations not exceeding 15% (mean ± SD). 5% Signiﬁcance level was adopted to compare data.
E. coli strains (SF = N60/N0)
Papain concentrations(μg/mL) AB1157 (WT) BW9091 (xthA) BH20 (fpg) PQ65 (rfa)
50 0.81 ± 0.04 1.00 ± 0.06 1.10 ± 0.05 0.98 ± 0.04
250 1.24 ± 0.08 1.40 ± 0.04 0.80 ± 0.02 1.04 ± 0.01
500 0.80 ± 0.06 1.10 ± 0.03 0.90 ± 0.04 0.93 ± 0.02
N e g a t i v ec o n t r o l0 . 9 %N a C l( 5 0μL) 1.00 ± 0.02 1.00 ± 0.05 0.90 ± 0.03 1.10 ± 0.04
Positive control H2O2 (10mM) 0.20∗± 0.01 0.003∗± 0.00004 0.17∗± 0.007 0.19∗± 0.01
The results are not signiﬁcantly diﬀerent (p>0.05) when compared to negative control.
∗The results are signiﬁcantly diﬀerent (p<0.05) when compared to negative control.
(b) Eﬀect of papain associated with talc on the survival of E. coli strains. Exponentially growing cultures were centrifuged, washed with 0.9% NaCl, and
suspended in the same solution. Aliquots (1mL) of these suspensions were incubated with diﬀerent papain concentrations (associated or not with talc) or
0.9% NaCl for 60 minutes, at 37◦C, with shaking. Afterwards, aliquots (100μL) were taken, diluted and plated onto LB medium for determining surviving
fractions (SF = N60/N0) for each strain. Values are the mean of 3 independent experiments (6 determinations) with standard deviations not exceeding 15%
(mean ± SD). 5% signiﬁcance level was adopted to compare data.
E. coli strains (SF = N60/N0)
Agents AB1157 (WT) BW9091 (xthA)
0.9% NaCl (negative control) 1.00 ± 0.02 1.00 ± 0.04
Papain (500μg/mL) 1.00 ± 0.03 0.93 ± 0.03
Papain associated with talc (500μg/mL) 0.80 ± 0.01 0.96 ± 0.03
Talc (500μg/mL) 0.90 ± 0.01 0.87 ± 0.02
H2O2 (10Mm) (positive control) 0.20∗± 0.004 0.003∗± 0.00004
The results are not signiﬁcantly diﬀerent (p>0.05) when compared to negative control.
∗The results are signiﬁcantly diﬀerent (p<0.05) when compared to negative control.
The data collected by densitometry provided us with
null events percentage (no breaks = p(0;μ)) for each one of
diﬀerentpapainconcentrationstested.Thus,themeanvalues
of breaks per genome for each one of the concentrations
using Poisson distribution were obtained as follows: μ =
−ln p(0;μ)[ 6].
3. Results
3.1. Cytotoxicity Assay. I no r d e rt oe v a l u a t et o x i ce ﬀects
of papain cytotoxicity assay was performed. The results
indicated that papain was not cytotoxic to E. coli strains
AB1157 (wild type), PQ65 (rfa), BH20 (fpg), and BW9091
(xthA) at the tested concentrations (Table 1(a)). Statistical
analysis indicated that there was no signiﬁcant diﬀerence
(p>0.05) among treated and untreated cells.
This same methodoly was used to test papain in asso-
ciation with talc, as shown in Table 1(b), and it was not
cytotoxic, either in the wild-type or in the repair mutant
(xthA) strain.
S i n c es o m er e p o r t s[ 16] preconize papain use in associa-
tion with talc, we also decided to address if talc would alter
cell viability. The results (Table 1(b)) showed that sterile talc
wasinert;thereforethesubsequenttestswereperformedwith
puriﬁed papain [10, 15].
3.2. Growth Inhibition Test. Another methodology to inves-
tigate the toxic eﬀect of papain comprised the use of Growth
inhibition test. The results concerning papain potential toxic
eﬀects obtained with E. coli IC203, IC204, IC205, IC206, and
IC207 strains revealed no formation of inhibition halos at
all tested concentrations. In fact, halos were produced only
with the positive control H2O2 (300μg/disc) (p<0.001)
when compared to negative control (0.9% NaCl), as shown
in Table 2.
3.3. Reverse Mutation Test in E. coli Strains (Mutoxitest).
The results obtained with WP2 Mutoxitest showed that all
the tested papain concentrations did not present mutagenic
activity with E. coli IC203 (WP2 uvrA oxyR pKM101) and
IC204 (WP2 uvrAd e lumuDC). There was no signiﬁcant
diﬀerence (p>0.05) when papain treatment was compared
to negative control (0.9% NaCl) (Table 3).
3.4. Plasmid DNA Treatment and Agarose Gel Electrophoresis.
Conformational changes in plasmid DNA (pUC 9.1) afterJournal of Biomedicine and Biotechnology 5
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Figure 1: Analysis of plasmid pUC 9.1 DNA strand breaks after treatment with papain. Aliquots of pUC 9.1 plasmid DNA (200ng) were
incubated with diﬀerent concentrations of papain for 40 minutes at 25◦C. Each sample was mixed with loading buﬀer and submitted to
0.8% agarose gel electrophoresis. The assay was repeated, at least three times. Densitometric measures were obtained from gel through Gel
Pro Analyzer 3.0 software. Lanes: (1) negative control (Milli-Q water); (2) positive control (H2O2 10mM); (3) 10μg; (4) 25μg; (5) 50μg; (6)
100μg; (7) 250μg; (8) 500μg of papain.
Table 2: Inhibition halos (mm) of the E. coli strains after treatment with diﬀerent papain concentrations mixed with hydrogen peroxide.
Aliquots (100μL) of exponentially growing cultures of E. coli w e r em i x e dw i t h3 m Lt o pa g a r( 4 4 – 4 6 ◦C) and spread on LB plates
supplemented with antibiotic (ampicillin or chloramphenicol, according to the strain resistance). After 15 minutes, paper discs (5mm
diameter) containing diﬀerent amounts of the papain (100 or 500μg/disc) mixed or not with H2O2 (300μg/disc) were placed in the center
of the plates. After 24-hour incubation at 37◦C the inhibition halos around the disc were measured. Values are the mean of 3 independent
experiments with standard deviations not exceeding 15% (mean ± SD). 5% signiﬁcance level was adopted to compare data.
Growth inhibition halos (mm) of E. coli strains
Agents (10μL/disc) IC203 IC204 IC205 IC206 IC207 WP2 (WT)
uvrA oxyR uvrA umuDC uvrA umuDC
mutM
uvrA umuDC
mutY
uvrA umuDC
mutM oxyR
H2O2 (300μg) 48.0 ± 1.4 30.5 ± 2.7 20.0 ± 2.4 17.0 ± 2.3 37.7 ± 1.0 16.0 ± 0.5
Papain (100μg) plus H2O2 (300μg) 45.0 ± 0.1∗ 22.0 ± 1.8∗ 21.5 ± 1.8 16.5 ± 1.7 33.5 ± 1.0∗∗ 15.6 ± 0.4
Papain (500μg) plus H2O2 (300μg) 40.5 ± 0.9∗ 22.0 ± 1.9∗ 20.0 ± 2.2 17.5 ± 2.0 35.5 ± 0.5∗∗ 15.4 ± 0.8
0.9% NaCl (negative control) ND ND ND ND ND ND
ND: not detected.
∗p<0.001 when compared to H2O2 (300μg/disc).
∗∗p<0.01 when compared to H2O2 (300μg/disc).6 Journal of Biomedicine and Biotechnology
Table 3: Mutoxitest—Number of Trp+ revertants/plate (mean ± SD). Aliquots (100μL) of exponentially growing cultures were mixed with
100μLo fd i ﬀerent concentrations of the papain or 0.9% NaCl, as negative control, and mixed with 2.5mL molten top agar at 45◦Ca n d
plated on minimal glucose agar plates supplemented with 0.5mg tryptophan/litre. The mutagenic responses were expressed as the absolute
number of Trp+ revertants/plate, after incubation at 37◦C, for 48 hours. Values are the mean of 3 independent experiments with standard
deviations not exceeding 15%.
Number of Trp+ revertants/plate (mean ± SD)
Agent (μg/plate) E. coli IC203 uvrA oxyR E. coli IC204 uvrA umuDC
Papain 5 158 ± 26.0 15 ± 3.0
Papain 25 162 ± 16.0 17 ± 3.0
Papain 50 154 ± 26.0 12 ± 3.0
Papain 100 129 ± 24.0 14 ± 3.0
Papain 125 178 ± 10.0 16 ± 3.0
Papain 250 162 ± 25.0 17 ± 3.0
Papain 500 149 ± 24.0 18 ± 3.0
Positive control H2O2 (300) 853∗± 70.2 15a± 1.9
Negative control 0.9% NaCl (50μL/plate) 141 ± 28.0 16 ± 4.0
aNumber of H2O2-induced revertants equivalent to that found with other genotoxic agents used by Blanco et al. in 1998.
∗p<0.001 when compared to negative control (0.9% NaCl).
treatment with diﬀerent concentrations of papain were also
investigated, using agarose gel electrophoresis analysis. Data
showed (Figure 1) that papain treatment did not modify
originalplasmidDNAconformationalstructure(supercoiled
form I).
4. Discussion
In patients from a Brazilian university public hospital (Pedro
Ernesto Hospital), papain, associated or not with talc, is
used for the topical treatment of chronic skin ulcer. It is
described as eﬀective and recommended in preference to
other dressings for the same purpose, as unripe papaya, in
other countries [15]. Physicians from this Hospital described
the following advantages of using the papain in comparison
with green papaya: dislodging of wounds, promotion of
granulation tissue and healing, cost-eﬀectiveness, standard-
ized procedure, facility in its availability, preparing, and
application [36].
Despite its extensive use in Brazilian patients, there is
still little information about papain toxicity. Then, as part
o fac o n t i n u o u se ﬀort to understand papain eﬀects, the aim
of this work was to extend knowledge concerning papain
toxicity mechanisms in bacterial systems and DNA plasmid.
Although usually recommended, exogenous metabolic acti-
vation system (S9 mix) was not included in the tests, since
papaintreatmentisonlyusedtopically,onchronicskinulcer,
and is not intended for internal use.
The phytotherapeutic agent papain was not able to
induce inactivation of all the E. coli strains tested.
Even E. coli PQ35 was as resistant as the wild type strain
(Table 1(a)). E. coli PQ65 is constitutively more permeable
to bulky molecules than the others E. coli strains used in
this work, due to one mutation (rfa) that causes partial loss
of the lipopolysaccharide barrier that coats the surface of
the bacteria [33]. Therefore, two hypotheses are possible: (i)
papain cannot penetrate the cell wall and exert its toxic eﬀect
even in PQ65 strain or (ii) it can penetrate the cell wall, but
it is not toxic.
DNA repair deﬁcient strains were also resistant to
papain treatment (Table 1(a)). Therefore, if papain induces
DNA damage, such as 8-oxoguanine, formamidopyrimidine
(Fapy), or even AP sites, they may not be produced at
levels high enough to cause cell lethality. Besides, one should
not discard other backup DNA repair/tolerance systems that
couldtaketheselesionsincharge,suchasnucleotideexcision
repair (NER) and recombination [37].
The antioxidant activity of papain against H2O2-induced
damage was also assessed using Growth inhibition test.
When the cells were simultaneously treated with H2O2
(300μg/disc) and papain (100 or 500μg/disc), there was
observed a signiﬁcant decrease in the growth-inhibition halo
of E. coli IC203 (WP2 uvrA oxyR pKM101) (p<0.001),
IC204 (WP2 uvrAd e lumuDC) (p<0.01), and IC207
(WP2 uvrAd e lumuDC mutM oxyR) (p<0.001) strains,
compared with the results obtained with H2O2 treatment
alone. Alternatively, there was no signiﬁcative decrease (p>
0.05) in the growth-inhibition halos with the other studied
strains, IC205 (uvrA umuDC mutM) and IC206 (uvrA
umuDC mutY) (Table 2). It is important to note that the
increase of papain to 500μg/disc was able to produce further
protection to IC203 (WP2 uvrA oxyR pKM101), but not
to all other strains. This indicates that papain excess may
prevent the production of DNA lesions majorly repaired by
nucleotide excision repair (uvrA) and by the oxyRt o l e r a n c e
system. In fact, when base excision repair (mutM and/or
mutY) or UmuD and UmuC proteins are absent, the excess
of papain is unable to produce further cell protection.
Mutoxitest is a potent assay to assess the ability of a
series of compounds to induce reversion of the trpE65
mutation in E. coli from auxotrophy to prototrophy [18]a n d
is currently accepted as a validated short-term genotoxicityJournal of Biomedicine and Biotechnology 7
test by international regulatory agencies [38]. The results
obtained with E. coli IC203, IC204, and IC207 strains treated
in presence of H2O2 can be interpreted as indicative of an
antioxidant property of papain. In this way, it can protect
against genotoxic and/or mutagenic eﬀects of H2O2, when
OxyR regulon and/or NER system are absent. On the other
hand, papain did not protect strains IC205 and IC206 from
the H2O2 deleterious eﬀects. These results, at ﬁrst sight,
seem to contrast with those about the antioxidant potential
of papain. However, they may also indicate that papain
could not prevent the generation of certain premutagenic
H2O2-induced lesions in DNA, such as 8-oxoguanine. It was
already observed that strains deﬁcient in MutM or MutY
DNA glicosilases are highly susceptible to SOS-independent
mutations promoted by these lesions [17]. In fact, papain
could be eﬃcient in scavenging only certain speciﬁc ROS
generated by H2O2 treatment, eliminating hydroxyl and/or
superoxide radicals, butnot singlet oxygen,the majorspecies
responsible for the formation of 8-oxoguanine lesions in
DNA [22, 39, 40].
CircularplasmidDNAwasusedinvitroastargettostudy
the induction of strand breaks in DNA by compounds such
as oxidant agents and natural products [6, 8, 41, 42]. Papain
did not induce single or double strand breaks in DNA in
vitro. In the context of the methodology used in this work,
these results reinforce the idea that the papain is neither a
cytoxicity nor genotoxic agent.
Our study indicates that papain is not toxic and/or
mutagenic in bacterial systems. Indeed, papain revealed to
be an antioxidant agent against H2O2-induced damage.
Webman and coworkers (1989) and Mehdipour and
coworkers (2006) demonstrated an antioxidant eﬀect of ripe
C. papaya L juice, which is poor in papain content. In
this case, the antioxidant properties found in papaya juice
cannot be unequivocally attributed to papain and may be
duetootherantioxidant substances.Infact,onlyunripe fruit
contains papain [12].
A problematic aspect in understanding potential toxico-
logical events relevant to the medicinal use of C. papaya L.
and many other medicinal plants is that the exact amounts
of active chemicals are unknown.
Oloyede (2005) studied unripe pulp of C. papaya and its
chemical compositon was determined [11]. In general, the
resultsfromthisphytochemicalscreeningsuggestthevalidity
of therapeutical eﬀect of aqueous extract of unripe pulp of
C. papaya. But studies on the toxicity of these compounds,
separately, were not performed.
Our results further support the notion that papain,
the compound isolated from latex of unripe C. papaya
L, is a promising source of potential antioxidant. A more
detailed investigation of papain for the antioxidant activity
is in progress using lower eukaryotic organisms, as yeast S.
cerevisiae.
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